Fineotex Chemical Limited — Others, 12-02-2025: Statement of deviation(s) or variation(s) under Reg. 32

Fineotex Chemical Limited has provided a statement confirming there are no deviations in the utilization of funds raised through its preferential issue of equity shares and convertible warrants for the quarter ended December 31, 2024. The company raised ₹56.28 crore and ₹136.32 crore in two funding rounds, with proceeds allocated to working capital and business expansion. The Audit Committee has reviewed and approved this statement, suggesting strong governance practices. From an investor's perspective, this update signals effective fund management, likely fostering a positive outlook among shareholders while reassuring them of operational integrity.